Cargando…
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies
Mutation-derived neoantigens represent an important class of tumour-specific, tumour rejection antigens, and are attractive targets for TCR gene therapy of cancer. The majority of such mutations are patient-specific and targeting these requires a fully personalized approach. However, some mutations...
Autores principales: | Tubb, Vanessa M., Schrikkema, Deborah S., Croft, Nathan P., Purcell, Anthony W., Linnemann, Carsten, Freriks, Manon R., Chen, Frederick, Long, Heather M., Lee, Steven P., Bendle, Gavin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044029/ https://www.ncbi.nlm.nih.gov/pubmed/30001747 http://dx.doi.org/10.1186/s40425-018-0386-y |
Ejemplares similares
-
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer
por: Santegoets, Saskia J., et al.
Publicado: (2022) -
Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020) -
Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019) -
Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies
por: Saini, Sunil Kumar, et al.
Publicado: (2022) -
Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets
por: Chen, Chao, et al.
Publicado: (2020)